chr3-10049365-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001018115.3(FANCD2):​c.1414-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0946 in 127,986 control chromosomes in the GnomAD database, including 265 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.095 ( 265 hom., cov: 31)
Exomes 𝑓: 0.063 ( 2996 hom. )
Failed GnomAD Quality Control

Consequence

FANCD2
NM_001018115.3 intron

Scores

2
Splicing: ADA: 0.00009997
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0450

Publications

7 publications found
Variant links:
Genes affected
FANCD2 (HGNC:3585): (FA complementation group D2) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
FANCD2 Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group D2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-10049365-C-T is Benign according to our data. Variant chr3-10049365-C-T is described in ClinVar as Benign. ClinVar VariationId is 241731.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 265 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001018115.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCD2
NM_001018115.3
MANE Select
c.1414-9C>T
intron
N/ANP_001018125.1
FANCD2
NM_033084.6
c.1414-9C>T
intron
N/ANP_149075.2
FANCD2
NM_001374254.1
c.1414-9C>T
intron
N/ANP_001361183.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCD2
ENST00000675286.1
MANE Select
c.1414-9C>T
intron
N/AENSP00000502379.1
FANCD2
ENST00000287647.7
TSL:1
c.1414-9C>T
intron
N/AENSP00000287647.3
FANCD2
ENST00000419585.5
TSL:1
c.1414-9C>T
intron
N/AENSP00000398754.1

Frequencies

GnomAD3 genomes
AF:
0.0946
AC:
12098
AN:
127898
Hom.:
265
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.166
Gnomad AMI
AF:
0.135
Gnomad AMR
AF:
0.0732
Gnomad ASJ
AF:
0.0729
Gnomad EAS
AF:
0.0346
Gnomad SAS
AF:
0.0850
Gnomad FIN
AF:
0.0519
Gnomad MID
AF:
0.0890
Gnomad NFE
AF:
0.0752
Gnomad OTH
AF:
0.0713
GnomAD2 exomes
AF:
0.0425
AC:
9170
AN:
215894
AF XY:
0.0403
show subpopulations
Gnomad AFR exome
AF:
0.178
Gnomad AMR exome
AF:
0.0444
Gnomad ASJ exome
AF:
0.0339
Gnomad EAS exome
AF:
0.0162
Gnomad FIN exome
AF:
0.0126
Gnomad NFE exome
AF:
0.0344
Gnomad OTH exome
AF:
0.0427
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0629
AC:
78280
AN:
1243568
Hom.:
2996
Cov.:
34
AF XY:
0.0632
AC XY:
39166
AN XY:
619370
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.191
AC:
5026
AN:
26376
American (AMR)
AF:
0.0616
AC:
2386
AN:
38760
Ashkenazi Jewish (ASJ)
AF:
0.0698
AC:
1594
AN:
22824
East Asian (EAS)
AF:
0.0266
AC:
1002
AN:
37712
South Asian (SAS)
AF:
0.0836
AC:
6147
AN:
73520
European-Finnish (FIN)
AF:
0.0422
AC:
2054
AN:
48722
Middle Eastern (MID)
AF:
0.0611
AC:
304
AN:
4976
European-Non Finnish (NFE)
AF:
0.0597
AC:
56005
AN:
938822
Other (OTH)
AF:
0.0725
AC:
3762
AN:
51856
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.322
Heterozygous variant carriers
0
6488
12976
19464
25952
32440
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1722
3444
5166
6888
8610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0946
AC:
12103
AN:
127986
Hom.:
265
Cov.:
31
AF XY:
0.0892
AC XY:
5589
AN XY:
62630
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.166
AC:
5228
AN:
31478
American (AMR)
AF:
0.0728
AC:
985
AN:
13532
Ashkenazi Jewish (ASJ)
AF:
0.0729
AC:
220
AN:
3018
East Asian (EAS)
AF:
0.0347
AC:
171
AN:
4934
South Asian (SAS)
AF:
0.0859
AC:
359
AN:
4180
European-Finnish (FIN)
AF:
0.0519
AC:
495
AN:
9538
Middle Eastern (MID)
AF:
0.0876
AC:
24
AN:
274
European-Non Finnish (NFE)
AF:
0.0751
AC:
4400
AN:
58554
Other (OTH)
AF:
0.0716
AC:
128
AN:
1788
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.327
Heterozygous variant carriers
0
925
1850
2775
3700
4625
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.180
Hom.:
752

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group D2 Benign:2
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 21, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Fanconi anemia Benign:1
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.8
DANN
Benign
0.40
PhyloP100
0.045
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00010
dbscSNV1_RF
Benign
0.0080
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35557429; hg19: chr3-10091049; COSMIC: COSV55036272; COSMIC: COSV55036272; API